Krognes Steve E.
Denali Therapeutics Inc. · director
Krognes Steve E. is listed in public filings as director. This Krognes Steve E. insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Denali Therapeutics Inc. (DNLI), and Guardant Health, Inc. (GH). Investors use Krognes Steve E.'s insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| --9.3k shares | SellJun 4, 2026 | $1.2M9.3k shares | $132.51 | $127.51 |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| --19.2k shares | Grant / ExerciseJun 3, 2026 | $378.0K19.2k shares | $19.66 | $20.21 | |
| --6.4k shares | Grant / ExerciseJun 3, 2026 | Disclosure amount unavailable6.4k shares | -- | $20.21 |